142 related articles for article (PubMed ID: 162334)
1. [Clinical relevance of circulating immune complexes in patients with systemic lupus erythematosus and chronic polyarthritis].
Menzel EJ; Smolen JS; Knapp W; Scherak O; Steffen C
Acta Med Austriaca; 1979; 6(5):212-4. PubMed ID: 162334
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis and systemic lupus erythematosus as immune complex diseases.
Weissmann G
Bull NYU Hosp Jt Dis; 2009; 67(3):251-3. PubMed ID: 19852746
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of circulating immune complex assay in patients with systemic lupus erythematosus.
Phi NC; Chien DK; Chinh DV; Péter G
Acta Med Hung; 1989; 46(2-3):109-20. PubMed ID: 2812955
[TBL] [Abstract][Full Text] [Related]
5. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
Bruneau C; Bonin H
Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
[TBL] [Abstract][Full Text] [Related]
7. [Anti-fibronectin autoantibodies in systemic lupus erythematosus, rheumatoid polyarthritis, and various viral or bacterial infectious diseases].
Henane T; Rigal D; Monier JC
Pathol Biol (Paris); 1986 Mar; 34(3):165-71. PubMed ID: 3517785
[TBL] [Abstract][Full Text] [Related]
8. Measurement of circulating immune complexes containing IgG, IgM, IgA and IgE by flow cytometry: correlation with disease activity in patients with systemic lupus erythematosus.
Kingsmore SF; Thompson JM; Crockard AD; Todd D; McKirgan J; Patterson C; Fay AC; McNeill TA
J Clin Lab Immunol; 1989 Sep; 30(1):45-52. PubMed ID: 2534927
[TBL] [Abstract][Full Text] [Related]
9. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B
J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
Cook AD; Rowley MJ; Wines BD; Mackay IR
J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
[TBL] [Abstract][Full Text] [Related]
11. Binding capacity of sera from systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) to C3c. Evaluation by enzyme linked immunosorbent assay (ELISA).
Bringuier JP; Veysseyre CM; Martin C; Raffin T; Monier JC
Pathol Biol (Paris); 1984 Dec; 32(10):1029-32. PubMed ID: 6514386
[TBL] [Abstract][Full Text] [Related]
12. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
13. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
[TBL] [Abstract][Full Text] [Related]
15. Anti-thyroglobulin anti-idiotypic antibodies in sera of patients with Hashimoto's thyroiditis and Graves' disease.
Sikorska HM
J Immunol; 1986 Dec; 137(12):3786-95. PubMed ID: 3782795
[TBL] [Abstract][Full Text] [Related]
16. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases.
Cook AD; Mackay IR; Cicuttini FM; Rowley MJ
J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865
[TBL] [Abstract][Full Text] [Related]
17. The significance of antibodies to poly(adenosine diphosphate-ribose) in systemic lupus erythematosus.
Okolie EE; Shall S
Clin Exp Immunol; 1979 Apr; 36(1):151-64. PubMed ID: 313859
[TBL] [Abstract][Full Text] [Related]
18. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
19. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
Greisman SG; Redecha PB; Kimberly RP; Christian CL
J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
[TBL] [Abstract][Full Text] [Related]
20. Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
Naama JK; Mitchell WS; Zoma A; Veitch J; Whaley K
Clin Exp Immunol; 1983 Feb; 51(2):292-8. PubMed ID: 6220848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
